Deinove (ALDEI.PA) Fundamental Analysis & Valuation

EPA:ALDEI • FR0010879056

Current stock price

0.0265 EUR
+0 (+13.25%)
Last:

This ALDEI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALDEI.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALDEI has reported negative net income.
  • In the past year ALDEI has reported a negative cash flow from operations.
ALDEI.PA Yearly Net Income VS EBIT VS OCF VS FCFALDEI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -2M -4M -6M -8M -10M

1.2 Ratios

  • ALDEI has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALDEI.PA Yearly ROA, ROE, ROICALDEI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -200 -400 -600 -800 -1K

1.3 Margins

  • ALDEI has a Gross Margin of 100.00%. This is amongst the best in the industry. ALDEI outperforms 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of ALDEI has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for ALDEI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 100%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y0%
ALDEI.PA Yearly Profit, Operating, Gross MarginsALDEI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -5K -10K -15K -20K -25K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ALDEI.PA Health Analysis

2.1 Basic Checks

  • ALDEI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALDEI has more shares outstanding than it did 1 year ago.
  • ALDEI has a worse debt/assets ratio than last year.
ALDEI.PA Yearly Shares OutstandingALDEI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M
ALDEI.PA Yearly Total Debt VS Total AssetsALDEI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 5M 10M 15M

2.2 Solvency

  • ALDEI has an Altman-Z score of -14.01. This is a bad value and indicates that ALDEI is not financially healthy and even has some risk of bankruptcy.
  • ALDEI has a Altman-Z score of -14.01. This is amonst the worse of the industry: ALDEI underperforms 91.80% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -14.01
ROIC/WACCN/A
WACC6.41%
ALDEI.PA Yearly LT Debt VS Equity VS FCFALDEI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 -5M -10M

2.3 Liquidity

  • ALDEI has a Current Ratio of 1.62. This is a normal value and indicates that ALDEI is financially healthy and should not expect problems in meeting its short term obligations.
  • ALDEI has a Current ratio (1.62) which is in line with its industry peers.
  • A Quick Ratio of 1.62 indicates that ALDEI should not have too much problems paying its short term obligations.
  • The Quick ratio of ALDEI (1.62) is better than 73.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.62
ALDEI.PA Yearly Current Assets VS Current LiabilitesALDEI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ALDEI.PA Growth Analysis

3.1 Past

  • ALDEI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.16%.
  • The Revenue for ALDEI has decreased by -44.04% in the past year. This is quite bad
  • ALDEI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.89% yearly.
EPS 1Y (TTM)-15.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.79%
Revenue 1Y (TTM)-44.04%
Revenue growth 3Y111.12%
Revenue growth 5Y6.89%
Sales Q2Q%-52.49%

3.2 Future

  • Based on estimates for the next years, ALDEI will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.08% on average per year.
  • The Revenue is expected to grow by 350.00% on average over the next years. This is a very strong growth
EPS Next Y-28.21%
EPS Next 2Y21.95%
EPS Next 3Y29.14%
EPS Next 5Y15.08%
Revenue Next Year100%
Revenue Next 2Y522.5%
Revenue Next 3Y274.44%
Revenue Next 5Y350%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALDEI.PA Yearly Revenue VS EstimatesALDEI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
ALDEI.PA Yearly EPS VS EstimatesALDEI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALDEI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALDEI. In the last year negative earnings were reported.
  • Also next year ALDEI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALDEI.PA Price Earnings VS Forward Price EarningsALDEI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALDEI.PA Per share dataALDEI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3 -0.4 -0.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALDEI's earnings are expected to grow with 29.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.95%
EPS Next 3Y29.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALDEI.PA Dividend Analysis

5.1 Amount

  • No dividends for ALDEI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ALDEI.PA Fundamentals: All Metrics, Ratios and Statistics

Deinove

EPA:ALDEI (1/10/2023, 7:00:00 PM)

0.0265

+0 (+13.25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Industry Strength53.38
Industry Growth36.67
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap873.86K
Revenue(TTM)230.00K
Net Income(TTM)-7.37M
Analysts84.44
Price Target0.61 (2201.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.8
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.01
BVpS-0.47
TBVpS-0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 100%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y0%
F-Score2
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 75.57%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.62
Altman-Z -14.01
F-Score2
WACC6.41%
ROIC/WACCN/A
Cap/Depr(3y)21.38%
Cap/Depr(5y)46.63%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.79%
EPS Next Y-28.21%
EPS Next 2Y21.95%
EPS Next 3Y29.14%
EPS Next 5Y15.08%
Revenue 1Y (TTM)-44.04%
Revenue growth 3Y111.12%
Revenue growth 5Y6.89%
Sales Q2Q%-52.49%
Revenue Next Year100%
Revenue Next 2Y522.5%
Revenue Next 3Y274.44%
Revenue Next 5Y350%
EBIT growth 1Y-8.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-9.45%
EBIT Next 3Y29.94%
EBIT Next 5Y15.3%
FCF growth 1Y-78.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.29%
OCF growth 3YN/A
OCF growth 5YN/A

Deinove / ALDEI.PA Fundamental Analysis FAQ

What is the fundamental rating for ALDEI stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALDEI.PA.


What is the valuation status of Deinove (ALDEI.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to Deinove (ALDEI.PA). This can be considered as Overvalued.


How profitable is Deinove (ALDEI.PA) stock?

Deinove (ALDEI.PA) has a profitability rating of 0 / 10.


What is the financial health of Deinove (ALDEI.PA) stock?

The financial health rating of Deinove (ALDEI.PA) is 2 / 10.